Tetsuo Sonomura
Papers
2
Total Citations
5
H-Index
2
About
Tetsuo Sonomura is a urologic oncologist whose research focuses on optimizing treatment strategies for prostate cancer, particularly high-risk disease. His work centers on comparing the oncological outcomes and health-related quality of life (HRQOL) between robot-assisted radical prostatectomy (RARP) and multimodal therapies, such as high-dose-rate brachytherapy combined with external beam radiation and hormone therapy. Sonomura has also explored the predictive value of preoperative MRI (PI-RADS v2) and biopsy findings for pathological extraprostatic extension, aiming to refine surgical planning and patient counseling. While his most-cited papers are recent (2022–2024), with 2–3 citations each, they represent emerging contributions to evidence-based decision-making in prostate cancer care. His research bridges surgical oncology, radiation oncology, and imaging, offering practical insights for clinicians managing high-risk patients. Sonomura’s work is particularly valuable for its focus on patient-reported outcomes and personalized risk stratification, areas increasingly central to modern urologic oncology. As his publication record grows, his comparative effectiveness studies may influence treatment guidelines and shared decision-making.
Research Focus
Key Achievements
Top Papers
- 1
- 2